Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS)
NCT07676539 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2026-07-08
Summary
The goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction of the intervention. The main questions it aims to answer are:
* Is STRW an acceptable, feasible, and satisfactory intervention for teens/young adults and their caregivers?
* Does STRW improve daily living skills (e.g., cooking, laundry, money management) for teens and young adults with epilepsy?
This is a nonrandomized pilot trial and all participants who enroll will:
* Participate in weekly caregiver/teen dyads ( approximately 60 minutes) focused on improving daily living skills with a trained therapist for 15 weeks.
* Participate in weekly caregiver groups (approximately 90 minutes) focused on supporting caregivers in coaching their teens in daily living skills development led by 2 trained therapists for 14 of the 15 intervention weeks.
* Complete measures of adaptive functioning (to evaluate daily living skills; parent and teen-report) at the start of the study and post-intervention. Additional measures will also be collected.
* Have the option to complete post-intervention interviews to provide feedback on the intervention components.
Conditions
- Epilepsy
- Epilepsy in Youth
- Activities, Daily Living
Interventions
- BEHAVIORAL
-
Surviving and Thriving in the Real World
The Surviving and Thriving in the Real World (STRW) intervention consists of 15 weekly caregiver-teen dyad sessions and 14 concurrent weekly caregiver group sessions delivered via Microsoft Teams. Daily Living Skills (DLS) targeted in the intervention include: morning routine, laundry, kitchen/cooking, grocery shopping, and money management. Evidence-based strategies are utilized to facilitate acquisition, mastery, and generalization of specific DLS at home and in the community. During dyad sessions, teens work on DLS in their home environment and will receive coaching and instruction from both their caregiver and the therapist. During caregiver group sessions, the therapist will discuss the content of dyad sessions and engage in problem solving with each caregiver.
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Avani Modi, Ph.D. · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-03
- Primary Completion
- 2026-07-01
- Completion
- 2026-07-01
Countries
- United States
Study Locations
More Related Trials
-
Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
NCT03350035 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
NCT01002820 ·Status: COMPLETED ·Phase: PHASE2
-
Steps for Epilepsy
NCT05359003 ·Status: COMPLETED ·Phase: NA
-
NYU Epilepsy Self-Management Study
NCT07087821 ·Status: RECRUITING ·Phase: NA
-
Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery
NCT05992402 ·Status: RECRUITING ·Phase: NA
-
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial
NCT07602205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
NCT03572933 ·Status: COMPLETED ·Phase: PHASE3
-
Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated
NCT01281293 ·Status: COMPLETED
-
Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
NCT02385526 ·Status: COMPLETED
-
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures
NCT00465517 ·Status: COMPLETED ·Phase: PHASE2
-
RNS System LGS Feasibility Study
NCT05339126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Goals for Epilepsy Clinic Visits Trial
NCT05928598 ·Status: RECRUITING ·Phase: NA
-
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
NCT01963208 ·Status: COMPLETED ·Phase: PHASE3
-
Early Surgical Intervention to Treat Epilepsy
NCT00040326 ·Status: COMPLETED ·Phase: PHASE3
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045 ·Status: COMPLETED
-
Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP)
NCT03643016 ·Status: RECRUITING ·Phase: NA
-
Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex
NCT02098759 ·Status: UNKNOWN ·Phase: NA
-
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
NCT02318537 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
NCT02834793 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
NCT03355209 ·Status: COMPLETED ·Phase: PHASE3
-
Cortical Excitability Assessment Using Paired Pulses
NCT02245061 ·Status: UNKNOWN ·Phase: NA
-
Stress Management Intervention for Living With Epilepsy (SMILE)
NCT01444183 ·Status: COMPLETED ·Phase: NA